Tech Company Financing Transactions

Inocucor Funding Round

TPG Alternative & Renewable Technologies, Cycle Capital and Desjardins Venture Capital invested in a $38.8 million Series B venture round for Inocucor. The funding round was announced on 3/29/2017.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

4600 South Ulster St. 1325
Denver, CO 80237
USA

Phone

(720) 543-0350

Website

www.inocucor.com

Email Address

[email protected]

Overview

Inocucor Technologies develops sustainable biological products for the phyto-microbiome that are safe for people and protect our natural resources.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Donald Marvin

        

VP - Finance

David Sisk

        

VP - Human Resources

Bonita Sonderby

        

VP - Manufacturing

Ramesh Murugesan

        

VP - Marketing

Timothy Sturm

        

VP - Product Management

Laura McIntosh

        

VP - R & D

Shawn Semones

        

Browse more venture capital transactions:

Prev: 3/29/2017: ControlUp venture capital transaction
Next: 3/29/2017: Smyte venture capital transaction

Share this article

News on VC Transactions

We do our best to record every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary